Management of myelofibrosis during pregnancy: A case report
Clicks: 277
ID: 63811
2015
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
65.1
/100
274 views
223 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Introduction. Primary myelofibrosis (PMF) is a clonal myeloproliferative
neoplasm that occurs most commonly in the decade six of life and it is very
rare in the young persons. Case report. We reported a 28-year-old female
patient with primary myelofibrosis who had a normal pregnancy and delivery in
the week 40 of pregnancy without any complications. Two years before the
diagnosis of PMF she had normal pregnancy. The patient was treated with
interferon-alpha and low dose aspirin during the whole pregnancy and with
low-molecular-weight heparin a week before delivery and 6 weeks after. The
patient had no complications during pregnancy. She delivered in term with
healthy, normal baby weight. Conclusion. Decision about treatment strategy of
pregnancy associated hematologic malignancies should be made for each patient
individually.
| Reference Key |
radmila2015managementvojnosanitetski
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Radmila, Živković;Olivera, Marković;Dragomir, Marisavljević;Tatjana, Terzić;Ljiljana, Tukić; |
| Journal | vojnosanitetski pregled |
| Year | 2015 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.